RxDoctor Payments Data

Hikmat Al-Ahmadie, MD

Pathology · Chicago, ILNPI 1982730602

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,583 of the $47,205 with a category attached, or 86.0%. 10 manufacturers reported payments, led by Astrazeneca UK Limited at 28.4% of the total. Reporting peaked in 2019 at $22,627 and has fallen 64.0% since, to $8,145 in 2025. Among pathology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,205in general payments, 2019–2025

Across 55 payments — averaging $858.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$13K
  • AstraZeneca$11K
  • Pfizer$6K
  • Astellas Pharma US Inc$5K
  • E.r. Squibb & Sons, L.L.C.$4K
  • Janssen Global Services, LLC$3K
  • plus $4K from 4 others
$387in research payments, 2019–2025

Across 1 payment — averaging $386.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$387

What the payments were for

  • Consulting fees$40,58386%
  • Speaking & faculty fees$2,0004%
  • Travel & lodging$3,5598%
  • Food & beverage$1,0642%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,205 in reported general payments places this provider in the 95th percentile of 205 pathology providers in Illinois.

See all pathology providers in Illinois

Medicare billing

Part B allowed, 2024
$56,051
Medicare patients
362
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pathology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →